{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:33:22Z","timestamp":1790386402163,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J003018\/1"],"award-info":[{"award-number":["BB\/J003018\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R000344\/1"],"award-info":[{"award-number":["BB\/R000344\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8717\/A18245"],"award-info":[{"award-number":["C8717\/A18245"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000728","name":"Trinity College, University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014679","name":"CRUK and EPSRC Cancer Imaging Centre Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106244\/Z\/14\/Z"],"award-info":[{"award-number":["106244\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jbc.2023.102873","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T11:26:49Z","timestamp":1672918009000},"page":"102873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-390X","authenticated-orcid":false,"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Reinbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-6269","authenticated-orcid":false,"given":"Ryan A.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul B.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine I.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Thieffine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser A.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-777X","authenticated-orcid":false,"given":"Lennart","family":"Brewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0290-6565","authenticated-orcid":false,"given":"Christopher J.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.102873_bib1","doi-asserted-by":"crossref","first-page":"33946","DOI":"10.1074\/jbc.M404298200","article-title":"Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity","volume":"279","author":"Xu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/biomedicines8090294","article-title":"Isocitrate dehydrogenase mutations in glioma: genetics, biochemistry, and clinical indications","volume":"8","author":"Liu","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2023.102873_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-biochem-061516-044732","article-title":"Isocitrate dehydrogenase mutation and (R)-2-hydroxyglutarate: from basic discovery to therapeutics development","volume":"86","author":"Dang","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2023.102873_bib4","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","article-title":"IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives","volume":"18","author":"Yang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2023.102873_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1101\/gad.217406.113","article-title":"What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer","volume":"27","author":"Losman","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2023.102873_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/ars.2019.7902","article-title":"2-Hydroxyglutarate in cancer cells","volume":"33","author":"Je\u017eek","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jbc.2023.102873_bib7","article-title":"Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations","volume":"2","author":"Hvinden","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jbc.2023.102873_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acsmedchemlett.7b00421","article-title":"Discovery of AG-120 (ivosidenib): a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers","volume":"9","author":"Popovici-Muller","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2023.102873_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/2159-8290.CD-16-1034","article-title":"AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations","volume":"7","author":"Yen","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2023.102873_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s42003-021-02743-5","article-title":"Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1","volume":"4","author":"Liu","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2023.102873_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-018-0251-7","article-title":"Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations","volume":"559","author":"Intlekofer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.102873_bib12","doi-asserted-by":"crossref","first-page":"a006007","DOI":"10.1101\/mcs.a006007","article-title":"Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling","volume":"7","author":"Oltvai","year":"2021","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.jbc.2023.102873_bib13","first-page":"552","article-title":"2-Oxoglutarate: Linking TCA cycle function with amino acid, glucosinolate, flavonoid, alkaloid, and gibberellin biosynthesis","volume":"5","author":"Ara\u00fajo","year":"2014","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.jbc.2023.102873_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mib.2005.02.011","article-title":"PII signal transduction proteins: Sensors of \u03b1-ketoglutarate that regulate nitrogen metabolism","volume":"8","author":"Ninfa","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jbc.2023.102873_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00005-016-0406-x","article-title":"Alpha-Ketoglutarate as a molecule with pleiotropic activity: well-known and novel possibilities of therapeutic use","volume":"65","author":"Zdzisi\u0144ska","year":"2017","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jbc.2023.102873_bib16","series-title":"2-Oxoglutarate-dependent Oxygenases","year":"2015"},{"key":"10.1016\/j.jbc.2023.102873_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2023.102873_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molmed.2011.06.001","article-title":"Revisiting the TCA cycle: signaling to tumor formation","volume":"17","author":"Raimundo","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2023.102873_bib19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/nrc.2016.85","article-title":"Altered metabolite levels in cancer: implications for tumour biology and cancer therapy","volume":"16","author":"Sullivan","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2023.102873_bib20","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/jacs.6b08653","article-title":"Engineering biological C\u2013H functionalization leads to allele-specific regulation of histone demethylases","volume":"138","author":"Breski","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.102873_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1039\/b101039p","article-title":"Chemical co-substrate rescue\u2019 of phytanoyl-CoA 2-hydroxylase mutants causing Refsum\u2019s Disease","author":"Mukherji","year":"2001","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jbc.2023.102873_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1039\/D0SC04301J","article-title":"Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate\/asparagine-\u03b2-hydroxylase","volume":"12","author":"Brewitz","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jbc.2023.102873_bib23","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1038\/s41467-021-26673-2","article-title":"2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases","volume":"12","author":"Nakashima","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.102873_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116141","article-title":"SAR insights into TET2 catalytic domain inhibition: synthesis of 2-hydroxy-4-methylene-pentanedicarboxylates","volume":"39","author":"Tiwari","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.abj5104","article-title":"Oncometabolite D-2HG alters T cell metabolism to impair CD8+ T cell function","volume":"377","author":"Notarangelo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.102873_bib26","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s41598-020-58701-4","article-title":"Synthetic analogues of 2-oxo acids discriminate metabolic contribution of the 2-oxoglutarate and 2-oxoadipate dehydrogenases in mammalian cells and tissues","volume":"10","author":"Artiukhov","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2023.102873_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0003-9861(86)90195-5","article-title":"\u03b2-Sulfur substituted \u03b1-ketoglutarates as inhibitors and alternate substrates for isocitrate dehydrogenases and certain other enzymes","volume":"245","author":"Plaut","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2023.102873_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/bi00507a037","article-title":"Interaction of isocitrate dehydrogenase with (RS)-3-bromo-2-ketoglutarate. A potential affinity label for \u03b1-ketoglutarate binding sites","volume":"20","author":"Hartman","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.102873_bib29","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/bi00258a025","article-title":"3-Bromo-2-ketoglutarate: a substrate and affinity label for DPN-dependent isocitrate dehydrogenase","volume":"21","author":"Bednar","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.102873_bib30","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1021\/bi00258a026","article-title":"3,4-Didehydro-2-ketoglutarate: an affinity label for DPN-dependent isocitrate dehydrogenase","volume":"21","author":"Bednar","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.102873_bib31","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1016\/S0021-9258(18)33824-9","article-title":"Chemical modification. A probe of the structure and function of the subunits of DPN-dependent isocitrate dehydrogenase","volume":"257","author":"Bednar","year":"1982","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib32","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1016\/S0021-9258(20)71301-3","article-title":"The role of dissimilar subunits of NAD-specific isocitrate dehydrogenase from pig heart. Evaluation using affinity labeling","volume":"259","author":"Ehrlich","year":"1984","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib33","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1016\/S0021-9258(18)45250-7","article-title":"Characterization of an active site peptide modified by the substrate analogue 3-bromo-2-ketoglutarate on a single chain of dimeric NADP+-dependent isocitrate dehydrogenase","volume":"262","author":"Ehrlich","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib34","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1021\/bi00447a023","article-title":"Cysteinyl peptide labeled by 3-bromo-2-ketoglutarate in the active site of pig heart NAD+-dependent isocitrate dehydrogenase","volume":"28","author":"Saha","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.102873_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0003-9861(92)90406-M","article-title":"Inactivation of pig heart NADP-specific isocitrate dehydrogenase by two affinity reagents is due to reaction with a cysteine not essential for function","volume":"293","author":"Smyth","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2023.102873_bib36","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1021\/jf00060a006","article-title":"Extractives from New Zealand honeys. 5. Aliphatic dicarboxylic acids in New Zealand rewarewa (Knightea excelsa) honey","volume":"43","author":"Wilkins","year":"1995","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-3796(17)30079-3","article-title":"Metabolism of \u03b3-methyl-\u03b1-ketoglutaric acid, \u03b3-methylene-\u03b1-ketoglutaric acid and other keto acids during the seedling growth in Tamarindus indica","volume":"166","author":"Mukherjee","year":"1974","journal-title":"Biochem. Physiol. Pflanz."},{"key":"10.1016\/j.jbc.2023.102873_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3891\/acta.chem.scand.09-0553","article-title":"New aminodicarboxylic acids and corresponding \u03b1-keto acids in Phyllitis scolopendrium","volume":"9","author":"Virtanen","year":"1955","journal-title":"Acta Chem. Scand."},{"key":"10.1016\/j.jbc.2023.102873_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.chroma.2016.01.010","article-title":"Told through the wine: a liquid chromatography\u2013mass spectrometry interplatform comparison reveals the influence of the global approach on the final annotated metabolites in non-targeted metabolomics","volume":"1433","author":"D\u00edaz","year":"2016","journal-title":"J.\u00a0Chromatogr. A."},{"key":"10.1016\/j.jbc.2023.102873_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.phytochem.2015.06.028","article-title":"The broad spectrum 2-oxoglutarate oxygenase inhibitor N-oxalylglycine is present in rhubarb and spinach leaves","volume":"117","author":"Al-Qahtani","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jbc.2023.102873_bib41","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1021\/bi400514k","article-title":"Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism","volume":"52","author":"Rendina","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.102873_bib42","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1039\/c0cs00203h","article-title":"Inhibition of 2-oxoglutarate dependent oxygenases","volume":"40","author":"Rose","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jbc.2023.102873_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1146\/annurev.bi.49.070180.005041","article-title":"Metabolism of proline and the hydroxyprolines","volume":"49","author":"Adams","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2023.102873_bib44","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbadis.2012.06.014","article-title":"4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition","volume":"1822","author":"Riedel","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2023.102873_bib45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/175703a0","article-title":"New soluble nitrogen compounds (amino- and imino-acids and amides) in plants","volume":"175","author":"Grobbelaar","year":"1955","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.102873_bib46","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1074\/jbc.M115.682054","article-title":"Structural and kinetic characterization of the 4-carboxy-2-hydroxymuconate hydratase from the gallate and protocatechuate 4,5-cleavage pathways of Pseudomonas putida KT2440","volume":"291","author":"Mazurkewich","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1073\/pnas.86.2.444","article-title":"Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase","volume":"86","author":"Stenflo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.102873_bib48","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1038\/s41467-019-12711-7","article-title":"Aspartate\/asparagine-\u03b2-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern","volume":"10","author":"Pfeffer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.102873_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102129","article-title":"Combined proteomic and biochemical analyses redefine the consensus sequence requirement for epidermal growth factor-like domain hydroxylation","volume":"298","author":"Brewitz","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib50","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1101\/gad.924501","article-title":"FIH-1: A novel protein that interacts with HIF-1\u03b1 and VHL to mediate repression of HIF-1 transcriptional activity","volume":"15","author":"Mahon","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2023.102873_bib51","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1074\/jbc.M312254200","article-title":"Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases","volume":"279","author":"Koivunen","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1074\/mcp.M800340-MCP200","article-title":"Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins","volume":"8","author":"Cockman","year":"2009","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jbc.2023.102873_bib53","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1038\/s41467-022-32436-4","article-title":"Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors","volume":"13","author":"Reinbold","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.102873_bib54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.102873_bib55","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1021\/acs.jpclett.1c01517","article-title":"Exploiting electrode nanoconfinement to investigate the catalytic properties of isocitrate dehydrogenase (IDH1) and a cancer-associated variant","volume":"12","author":"Herold","year":"2021","journal-title":"J.\u00a0Phys. Chem. Lett."},{"key":"10.1016\/j.jbc.2023.102873_bib56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1039\/C1CC16699A","article-title":"Spin echo NMR spectra without J modulation","volume":"48","author":"Aguilar","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jbc.2023.102873_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/bj1660225","article-title":"Effect of glucagon on metabolite compartmentation in isolated rat liver cells during gluconeogenesis from lactate","volume":"166","author":"Siess","year":"1977","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2023.102873_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.phrs.2011.03.017","article-title":"Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors","volume":"64","author":"Thirstrup","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbc.2023.102873_bib59","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.3390\/cancers12102842","article-title":"(2R,3S)-Dihydroxybutanoic acid synthesis as a novel metabolic function of mutant isocitrate dehydrogenase 1 and 2 in acute myeloid leukemia","volume":"12","author":"Idle","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jbc.2023.102873_bib60","doi-asserted-by":"crossref","first-page":"25180","DOI":"10.1074\/jbc.M910040199","article-title":"Molecular basis for differential substrate specificity in class IV alcohol dehydrogenases","volume":"275","author":"Crosas","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-1987-27830","article-title":"Enantioselective reduction of vicinally substituted monocyclic aldehydes with horse liver alcohol dehydrogenase; a new approach to chiral alcohols and aldehydes","volume":"1987","author":"Boland","year":"1987","journal-title":"Synthesis"},{"key":"10.1016\/j.jbc.2023.102873_bib62","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/ja00272a051","article-title":"Organic synthesis with enzymes. 3. TBADH-catalyzed reduction of chloro ketones. Total synthesis of (+)-(S,S)-(cis-6-methyltetrahydropyran-2-yl)acetic acid: a civet constituent","volume":"108","author":"Keinan","year":"1986","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.102873_bib63","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1021\/ja00217a044","article-title":"L-lactate dehydrogenase: Substrate specificity and use as a catalyst in the synthesis of homochiral 2-hydroxy acids","volume":"110","author":"Kim","year":"1988","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.102873_bib64","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1016\/S0040-4039(00)74747-2","article-title":"Stereoselective routes to chiral 2-hydroxy-4-oxo acids and substituted 2-hydroxybutyrolactones using lactate dehydrogenases","volume":"33","author":"Casy","year":"1992","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jbc.2023.102873_bib65","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1021\/jo502529g","article-title":"Enantiomerically pure 3-aryl- and 3-hetaryl-2-hydroxypropanoic acids by chemoenzymatic reduction of 2-oxo acids","volume":"80","author":"Sivanathan","year":"2015","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.jbc.2023.102873_bib66","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1615-4169(200108)343:6\/7<692::AID-ADSC692>3.0.CO;2-6","article-title":"Synthesis of 4,4-disubstituted L-glutamic acids by enzymatic transamination","volume":"343","author":"H\u00e9laine","year":"2001","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.jbc.2023.102873_bib67","series-title":"Biotransformations in Organic Chemistry: A Textbook","author":"Faber","year":"2018"},{"key":"10.1016\/j.jbc.2023.102873_bib68","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/op010232y","article-title":"Development of a continuous enzymatic process for the preparation of (R)-3-(4-fluorophenyl)-2-hydroxy propionic acid","volume":"6","author":"Tao","year":"2002","journal-title":"Org. Proc. Res. Dev."},{"key":"10.1016\/j.jbc.2023.102873_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s43586-021-00044-z","article-title":"Biocatalysis","volume":"1","author":"Bell","year":"2021","journal-title":"Nat. Rev. Met. Primers"},{"key":"10.1016\/j.jbc.2023.102873_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.132001","article-title":"Lactones: classification, synthesis, biological activities, and industrial applications","volume":"84","author":"Sartori","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jbc.2023.102873_bib71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1107\/S0021889809045701","article-title":"xia2: an expert system for macromolecular crystallography data reduction","volume":"43","author":"Winter","year":"2010","journal-title":"J.\u00a0Appl. Cryst."},{"key":"10.1016\/j.jbc.2023.102873_bib72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Cryst."},{"key":"10.1016\/j.jbc.2023.102873_bib73","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Cryst. D"},{"key":"10.1016\/j.jbc.2023.102873_bib74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"Phenix: a comprehensive python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Cryst. D"},{"key":"10.1016\/j.jbc.2023.102873_bib75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.str.2016.12.017","article-title":"Allosteric mutant IDH1 inhibitors reveal mechanisms for IDH1 mutant and isoform selectivity","volume":"25","author":"Xie","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2023.102873_bib76","first-page":"iv","article-title":"The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves","volume":"40","author":"Hill","year":"1910","journal-title":"J.\u00a0Physiol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:38:58Z","timestamp":1758242338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0021925823000054"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.102873","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.102873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102873"}}